TRPC4 and prostate carcinoma: A literature published in 2019 suggests that TRPC4 can be used as an independent influencing factor to determine the risk of recurrence after radical prostate cancer surgery: high expression of TRPC4 is associated with a lower risk of recurrence (Perrouin-Verbe et al., 2019).